Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 2/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.36 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11553723 | 0.81 | MAPT (0.44) | MAPTKMT2AALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL10386947 | 0.75 | SIGMAR1 (0.54) | MAPTKMT2AALDH1A1SIGMAR1NPC1 | |
| SCHEMBL6360683 | 0.75 | MEN1 (0.54) | MAPTKMT2AALDH1A1SIGMAR1NPC1 | |
| Bromide SCHEMBL10800477 | 0.73 | SIGMAR1 (0.52) | MAPTKMT2AALDH1A1SIGMAR1NPC1 | |
| SCHEMBL11188803 | 0.73 | DDB1 (0.42) | MAPTKMT2AALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL28566678 | 0.72 | MAPT (0.58) | MAPTKMT2AALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL3257577 | 0.70 | SIGMAR1 (0.58) | MAPTKMT2ASIGMAR1NPC1RAB9A | |
| SCHEMBL13917942 | 0.67 | ATM (0.49) | MAPTKMT2ASIGMAR1NPC1RAB9A | |
| SCHEMBL10416940 | 0.67 | KMT2A (0.58) | MAPTKMT2AALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL23769116 | 0.66 | MAPT (0.42) | MAPTKMT2AALDH1A1CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114514936-A | Application of thiazole thione in preparing bird repellent | 宁波三江益农化学有限公司 | 2022-05-20 | — | — | CN | claimed |
| EP-3826982-B1 | USE OF A SUBSTITUTED THIAZOLIDINE COMPOUND AS NITRIFICATION INHIBITOR | BASF SE (DE) | 2023-11-01 | — | — | EP | disclosed |
| CN-114514936-B | Application of thiazole thioketone in preparation of bird repellent | 宁波三江益农化学有限公司 | 2023-08-18 | — | — | CN | disclosed |
| CN-112955503-B | Chloroprene rubber composition and vulcanized molded article | 电化株式会社 | 2022-10-21 | — | — | CN | disclosed |
| CN-114514936-A | Application of thiazole thione in preparing bird repellent | 宁波三江益农化学有限公司 | 2022-05-20 | — | — | CN | disclosed |
| CN-114514936-A | Application of thiazole thione in preparing bird repellent | 宁波三江益农化学有限公司 | 2022-05-20 | — | — | CN | disclosed |
| EP-3862389-B1 | CHLOROPRENE RUBBER COMPOSITION AND VULCANIZATION MOLDED BODY | DENKA COMPANY LTD (JP) | 2022-02-23 | — | — | EP | disclosed |
| US-20220002526-A1 | CHLOROPRENE RUBBER COMPOSITION AND VULCANIZATION MOLDED BODY | DENKA COMPANY LIMITED (JP) | 2022-01-06 | — | — | US | disclosed |
| US-20210276930-A1 | USE OF A SUBSTITUTED THIAZOLIDINE COMPOUND AS NITRIFICATION INHIBITOR | BASF SE (DE) | 2021-09-09 | — | — | US | disclosed |
| EP-3862389-A1 | CHLOROPRENE RUBBER COMPOSITION AND VULCANIZATION MOLDED BODY | Denka Company Limited (JP) | 2021-08-11 | — | — | EP | disclosed |
| EP-1954652-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF ARMODAFINIL | Teva Pharmaceutical Industries Ltd (IL) | 2008-08-13 | — | — | EP | disclosed |
| WO-2008039829-A2 | DIPHENYLHETEROCYCLE CHOLESTEROL ABSORPTION INHIBITORS | IRONWOOD PHARMACEUTICALS, INC. (US) | 2008-04-03 | — | — | WO | disclosed |
| US-20080031939-A1 | Process for the preparation of armodafinil | TEVA PHARMACEUTICALS USA, INC. | 2008-02-07 | — | — | US | disclosed |
| WO-2007103221-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF ARMODAFINIL | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2007-09-13 | — | — | WO | disclosed |
| WO-2006102674-A2 | DIPHENYLHETEROCYCLE CHOLESTEROL ABSORPTION INHIBITORS | MICROBIA, INC. (US) | 2006-09-28 | — | — | WO | disclosed |
| EP-0988295-A4 | HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF | SYNAPTIC PHARMA CORP (US) | 2003-08-13 | — | — | EP | disclosed |
| EP-0988295-A1 | HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 2000-03-29 | — | — | EP | disclosed |
| WO-1998057940-A1 | HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 1998-12-23 | — | — | WO | disclosed |
| EP-0017039-B1 | PROCESS FOR THE PREPARATION OF THIAZOLIDINE-2-THIONES | BAYER AG (DE) | 1983-01-12 | — | — | EP | disclosed |
| EP-0017039-A1 | Process for the preparation of thiazolidine-2-thiones | BAYER AG (DE) | 1980-10-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080031939-A1 | Process for the preparation of armodafinil | CYP2F1, CYP4F11, CYP4F2 | MAPT 2192/4885KMT2A 2108/4885ALDH1A1 344/4885 |
| US-20210276930-A1 | USE OF A SUBSTITUTED THIAZOLIDINE COMPOUND AS NITRIFICATION INHIBITOR | NAT1, NOS1, NOS2 | MAPT 2278/4885KMT2A 2909/4885ALDH1A1 332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.